Indian Council of Medical Research (ICMR) has received royalty of ₹171.74 crore till 31st January, 2022 from Bharat Biotech from sales of COVID vaccine Covaxin. The Council has spent around ₹35 crore in research and development of Covaxin.
Funds with ICMR are utilised for health research activities, including emerging research priorities and research capacity building, the Health Ministry told the Upper House of Parliament on Tuesday in response to a question by Leader of Opposition in the Rajya Sabha Mallikarjun Kharge.